However, the beneficial effects of secukinumab on inhibiting psoriasis-related markers and restoring KRT1 expression were significantly reduced in the presence of overexpression of RHCG (oe-RHCG) or HIF-1α (oe-HIF1A) [Fig. 8(l)]. Here, KRT1 is linked to psoriasis.